Czech National Bank Buys 7,954 Shares of Danaher Corporation $DHR

Czech National Bank grew its position in Danaher Corporation (NYSE:DHR) by 4.6% during the 2nd quarter, Holdings Channel reports. The firm owned 179,298 shares of the conglomerate’s stock after purchasing an additional 7,954 shares during the quarter. Czech National Bank’s holdings in Danaher were worth $34,153,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in DHR. State Street Corp lifted its holdings in Danaher by 1.7% during the 4th quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock valued at $6,345,529,000 after purchasing an additional 472,608 shares during the last quarter. Capital International Investors increased its holdings in shares of Danaher by 8.9% during the fourth quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock worth $4,177,386,000 after buying an additional 1,487,768 shares in the last quarter. Price T Rowe Associates Inc. MD increased its holdings in shares of Danaher by 9.1% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate’s stock worth $3,656,595,000 after buying an additional 1,334,221 shares in the last quarter. Wellington Management Group LLP raised its stake in shares of Danaher by 11.2% in the fourth quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate’s stock valued at $3,451,380,000 after acquiring an additional 1,517,904 shares during the last quarter. Finally, Norges Bank acquired a new position in shares of Danaher in the 4th quarter worth approximately $2,177,106,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analysts Set New Price Targets

DHR has been the subject of a number of recent analyst reports. HSBC dropped their price target on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. Guggenheim lowered their target price on Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. Evercore reiterated an “outperform” rating and set a $230.00 price target on shares of Danaher in a research report on Monday, July 6th. Barclays lowered their price objective on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a research report on Tuesday, April 14th. Finally, Piper Sandler initiated coverage on shares of Danaher in a research note on Thursday, June 11th. They issued a “neutral” rating and a $200.00 target price for the company. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $228.91.

Danaher Trading Up 0.2%

Shares of DHR opened at $200.01 on Friday. The stock’s fifty day simple moving average is $190.23 and its 200-day simple moving average is $194.24. The firm has a market capitalization of $140.61 billion, a PE ratio of 35.53, a price-to-earnings-growth ratio of 2.49 and a beta of 0.78. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company’s revenue was up 5.5% on a year-over-year basis. During the same period last year, the company earned $0.77 earnings per share. As a group, research analysts predict that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.